The following instruments on XETRA do have their last trading day on 06.02.2013 Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am 06.02.2013 ISIN BMG7242E1057 CA4659271015 CA8585721001 US92921W1027 VGG6844A1075
| 0,293 Euro | -0,002 -0,68 % | ||
| WKN: A1KCM7 ISIN: VGG6844A1158 Ticker-Symbol: 3PON | Frankfurt | 17.05.13 | 09:07 Uhr |
Branche Öl/GasAktienmarkt Sonstige |
|
The following instruments on XETRA do have their last trading day on 06.02.2013 Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am 06.02.2013 ISIN BMG7242E1057 CA4659271015 CA8585721001 US92921W1027 VGG6844A1075
| Zeit | Aktuelle Nachrichten | |
|---|---|---|
| 16.05. | Polo Resources could spin out assets 'sooner rather than later', new backer says | |
Mehr lesen zu: Polo Resources could spin out assets 'sooner rather than later', new backer says | ||
| 15.05. | UPDATE: Polo Resources shares advance as Malaysian investor moves in | |
Mehr lesen zu: UPDATE: Polo Resources shares advance as Malaysian investor moves in | ||
| 15.05. | Polo Resources appoints new co-chairman | |
Mehr lesen zu: Polo Resources appoints new co-chairman | ||
| 14.05. | GCM Resources PLC: Polo Resources change in management | |
Mehr lesen zu: GCM Resources PLC: Polo Resources change in management | ||
| 14.05. | Polo Resources Ltd: Mettiz Capital Ltd becomes Largest Shareholder | |
Mehr lesen zu: Polo Resources Ltd: Mettiz Capital Ltd becomes Largest Shareholder |
| Zeit | Aktuelle Nachrichten | |
|---|---|---|
| 06.02. | XFRA FRA: DELETION OF INSTRUMENTS FROM XETRA - 06.02.2013 | |
| The following instruments on XETRA do have their last trading day on
06.02.2013
Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am
06.02.2013
ISIN
BMG7242E1057
CA4659271015
... Mehr lesen zu: XFRA FRA: DELETION OF INSTRUMENTS FROM XETRA - 06.02.2013 | ||
| 17.01. | XFRA 7PC: AUSSETZUNG/SUSPENSION | |
| DIE FOLGENDE AKTIE IST AB SOFORT AUSGESETZT:
THE FOLLOWING SHARE IS SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
Primary Capital 7PC BMG7242E1057 BAW/UFN Mehr lesen zu: XFRA 7PC: AUSSETZUNG/SUSPENSION | ||
| 17.12. | XFRA FRA:New Instruments available on XETRA - 17.12.2012-001 | |
| The following instruments on XETRA do have their first trading day
17.12.2012
Die folgenden Instrumente in XETRA haben ihren ersten Handelstag am
17.12.2012
TrdMod InstCode Exch ISIN Name InstGrp... Mehr lesen zu: XFRA FRA:New Instruments available on XETRA - 17.12.2012-001 |
| Zeit | Aktuelle Nachrichten | |
|---|---|---|
| 15:05 | Stem Cell Therapeutics Begins Trading on OTCQX | |
| NEW YORK, May 20, 2013 /PRNewswire/ --OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced that Stem Cell Therapeutics Corp. (OTCQX:... Mehr lesen zu: Stem Cell Therapeutics Begins Trading on OTCQX | ||
| 16.05. | Stem Cell Therapeutics reports completion of Phase I study dosing | |
Mehr lesen zu: Stem Cell Therapeutics reports completion of Phase I study dosing | ||
| 16.05. | Stem Cell Therapeutics Corp (2): Stem Cell to begin trading on OTCQX May 20 | |
Mehr lesen zu: Stem Cell Therapeutics Corp (2): Stem Cell to begin trading on OTCQX May 20 | ||
| 16.05. | Stem Cell Therapeutics to Begin Trading on the U.S. OTCQX Marketplace | |
| TORONTO, ONTARIO -- (Marketwired) -- 05/16/13 -- Stem Cell Therapeutics Corp. (TSX VENTURE: SSS), a biopharmaceutical company developing cancer stem cell-related technologies, today announced that... Mehr lesen zu: Stem Cell Therapeutics to Begin Trading on the U.S. OTCQX Marketplace | ||
| 16.05. | Stem Cell Therapeutics Announces Completion of Dosing in Phase I Study of TTI-1612 in Patients With Interstitial Cystitis/Bladder Pain Syndrome | |
| TORONTO, ONTARIO -- (Marketwired) -- 05/16/13 -- Stem Cell Therapeutics Corp. (TSX VENTURE: SSS), a biopharmaceutical company developing cancer stem cell-related technologies, today announced that... Mehr lesen zu: Stem Cell Therapeutics Announces Completion of Dosing in Phase I Study of TTI-1612 in Patients With Interstitial Cystitis/Bladder Pain Syndrome |
| Zeit | Aktuelle Nachrichten | |
|---|---|---|
| 14.05. | SAP und Vuzix stellen Datenbrille für Profis vor | |
Mehr lesen zu: SAP und Vuzix stellen Datenbrille für Profis vor | ||
| 10.05. | Vuzix Corp (2): Vuzix, Brison work on augmented reality applications | |
Mehr lesen zu: Vuzix Corp (2): Vuzix, Brison work on augmented reality applications | ||
| 10.05. | Vuzix to Unleash the Power of Augmented Reality and Real-Time Data Access at SAP's SAPPHIRE NOW 2013 | |
| NEW YORK, May 10, 2013 /PRNewswire/ --Vuzix Corporation (TSX-V: VZX, OTC:BB: VUZI, FMB: V7X), a leading developer and supplier of smart glasses, today announced that it has been working with Paul... Mehr lesen zu: Vuzix to Unleash the Power of Augmented Reality and Real-Time Data Access at SAP's SAPPHIRE NOW 2013 | ||
| 01.05. | Vuzix Corp (2): Vuzix sells out of M100 smart glasses kits | |
Mehr lesen zu: Vuzix Corp (2): Vuzix sells out of M100 smart glasses kits | ||
| 01.05. | Vuzix Sells Out of Gold Software Developer Kits for New M100 Smart Glasses | |
| NEW YORK, May 1, 2013 /PRNewswire/ --Vuzix Corporation (TSX-V: VZX, OTC:BB: VUZI, FMB: V7X), the leading developer and supplier of smart glasses, announced that driven by strong demand, its initial... Mehr lesen zu: Vuzix Sells Out of Gold Software Developer Kits for New M100 Smart Glasses |
| Aktie | Kurs | % |
|---|---|---|
| POLO RESOURCES LTD | 0,293 | -0,68 % |
| PRIMARY CAPITAL LTD | 0,24 | -16,96 % |
| STEM CELL THERAPEUTICS CORP | 0,075 | -3,85 % |
| VUZIX CORPORATION | 5,55 | +0,91 % |